Status:
COMPLETED
Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery
Lead Sponsor:
University Hospital Ostrava
Conditions:
Nicotine Dependence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to determine whether the application of transdermal nicotine patches in critically ill patients after major surgery with nicotine abstinence condition is associa...
Detailed Description
Patients in a group with medical intervention receive nicotine patch within 24 hours after surgery. The nicotine patch is replaced every day. Delirium is evaluated every day by the Confusion Assessmen...
Eligibility Criteria
Inclusion
- Patients undergoing a surgical procedure - urological, surgical, trauma surgery, orthopedic surgery, dental surgery)
- Age 18 years and above
- Patient with an assumption of nicotine abstinence (smoking a minimum 10 cigarettes/day).
- Ex-smokers (if they stopped smoking less than 30 days prior to surgery)
- An assumption of hospitalization at the intensive care unit (ICU) after surgery
- Signed Informed consent
Exclusion
- Age ˂ 18 years
- Non-signing of the informed consent
- Patients after neurosurgical surgery, patients with traumatic brain injury, patients after a new stroke
- Patients with psychiatric diseases
- Nicotine, Curapor or Hydrocoll allergy
- Patient with a heart attack, unstable angina pectoris or patients with a serious heart arrhythmia
- Pregnant and breastfeeding patients
- Patients with nicotine treatment
Key Trial Info
Start Date :
September 23 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 8 2021
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03847155
Start Date
September 23 2015
End Date
February 8 2021
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia, 70852